Literature DB >> 1080403

Proteinase inhibitors in rheumatoid arthritis.

D Brackertz, J Hagmann, F Kueppers.   

Abstract

The concentrations of five normally occurring protease inhibitors in serum and synovial fluid were compared in patients with rheumatoid arthritis, osteoarthrosis, and normal controls. The patients with rheumatoid arthritis showed a significant rise in alpha1-antitrypsin, alpha1-antichymotrypsin, and inter-alpha-trypsin inhibitor (in decreasing order) in serum as well as in synovial fluid. In synovial fluid the inhibitors were present in their native form and bound to hyaluronate. A large molecular protein with immunological specificity of alpha1-antitrypsin, presumably a complex of alpha1-antitrypsin and a protease, could be shown in synovial fluid of all patients with classical and probable rheumatoid arthritis and not in that of the other subjects studied.23Author

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1080403      PMCID: PMC1006401          DOI: 10.1136/ard.34.3.225

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  15 in total

1.  BINDING OF AN ALPHA GLOBULIN TO HYALURONATEPROTEIN IN PATHOLOGICAL SYNOVIAL FLUIDS.

Authors:  J SANDSON; D HAMERMAN
Journal:  Science       Date:  1964-10-02       Impact factor: 47.728

2.  A BIOCHEMICAL ABNORMALITY IN HEREDIATRY ANGIONEUROTIC EDEMA: ABSENCE OF SERUM INHIBITOR OF C' 1-ESTERASE.

Authors:  V H DONALDSON; R R EVANS
Journal:  Am J Med       Date:  1963-07       Impact factor: 4.965

3.  HEREDITARY ANGIONEUROTIC EDEMA: TWO GENETIC VARIANTS.

Authors:  F S ROSEN; J PENSKY; V DONALDSON; P CHARACHE
Journal:  Science       Date:  1965-05-14       Impact factor: 47.728

4.  1958 Revision of diagnostic criteria for rheumatoid arthritis.

Authors:  M W ROPES; G A BENNETT; S COBB; R JACOX; R A JESSAR
Journal:  Bull Rheum Dis       Date:  1958-12

5.  A theoretical and experimental analysis of double diffusion precipitin reactions in gels, and its application to characterization of antigens.

Authors:  A C ALLISON; J H HUMPHREY
Journal:  Immunology       Date:  1960-01       Impact factor: 7.397

6.  [A micro-method of immuno-electrophoresis].

Authors:  J J SCHEIDEGGER
Journal:  Int Arch Allergy Appl Immunol       Date:  1955

7.  Degradation of collagen by a human granulocyte collagenolytic system.

Authors:  G S Lazarus; J R Daniels; R S Brown; H A Bladen; H M Fullmer
Journal:  J Clin Invest       Date:  1968-12       Impact factor: 14.808

8.  Sequential changes of plasma proteins after surgical trauma.

Authors:  K F Aronsen; G Ekelund; C O Kindmark; C B Laurell
Journal:  Scand J Clin Lab Invest Suppl       Date:  1972

9.  C1 inactivator protein complexed with albumin in plasma from a patient with angioneurotic edema.

Authors:  A B Laurell; U Mårtensson
Journal:  Eur J Immunol       Date:  1971-04       Impact factor: 5.532

10.  Genetically determined differences in the response of alpha-antitrypsin levels in human serum to typhoid vaccine.

Authors:  F Kueppers
Journal:  Humangenetik       Date:  1968
View more
  11 in total

Review 1.  The role of the macrophage in collagen resorption during chronic inflammation. A new look at an old hypothesis.

Authors:  D A Deporter
Journal:  Agents Actions       Date:  1979-06

2.  Protease and antiprotease levels in blood of arthritic rats.

Authors:  D P Parrott; D A Lewis
Journal:  Ann Rheum Dis       Date:  1977-04       Impact factor: 19.103

3.  Adjuvant-induced inflammatory disease in the rat: plasma levels of peptide hydrolases and protease inhibitors reflect disease activity.

Authors:  H P Schnebli
Journal:  Agents Actions       Date:  1979-12

4.  Human mononuclear cell factors mediate cartilage matrix degradation through chondrocyte activation.

Authors:  H E Jasin; J T Dingle
Journal:  J Clin Invest       Date:  1981-09       Impact factor: 14.808

Review 5.  Lysosomal elastase: effect on mechanical and biochemical properties of normal cartilage, inhibition by polysulfonated glycosaminoglycan, and binding to chondrocytes.

Authors:  H Menninger; H Burkhardt; W Röske; W Ehlebracht; B Hering; E Gurr; W Mohr; H D Mierau
Journal:  Rheumatol Int       Date:  1981       Impact factor: 2.631

6.  Study of enzyme inhibitors in the rheumatoid pannus-cartilage area.

Authors:  E D Flory; K D Muirden
Journal:  Rheumatol Int       Date:  1983       Impact factor: 2.631

7.  Protease inhibitors in rheumatoid synovial fluid. Analyses of electrophoretic homogeneity and protease inhibitory capacity.

Authors:  L Ekerot; K Ohlsson
Journal:  Rheumatol Int       Date:  1982       Impact factor: 2.631

Review 8.  Reference distributions for alpha2-macroglobulin: a comparison of a large cohort to the world's literature.

Authors:  Robert F Ritchie; Glenn E Palomaki; Louis M Neveux; Olga Navolotskaia
Journal:  J Clin Lab Anal       Date:  2004       Impact factor: 2.352

9.  Binding of haptoglobin, inter-alpha-trypsin inhibitor, and alpha 1 proteinase inhibitor to synovial fluid hyaluronate and the influence of these proteins on its degradation by oxygen derived free radicals.

Authors:  N Hutadilok; P Ghosh; P M Brooks
Journal:  Ann Rheum Dis       Date:  1988-05       Impact factor: 19.103

10.  A tissue kallikrein in the synovial fluid of patients with rheumatoid arthritis.

Authors:  B M Selwyn; C D Figueroa; E Fink; A Swan; P A Dieppe; K D Bhoola
Journal:  Ann Rheum Dis       Date:  1989-02       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.